Clinical, economical and safety impact of ferric carboxymaltose use in Patient Blood Management programme in Portuguese National Health Service hospitals

Ferric carboxymaltose (FCM) can be used in Patient Blood Management (PBM) to promote the optimization of preoperative haemoglobin (Hb), which aims to minimise the use of allogeneic blood components and improve clinical outcomes, with better cost-effectiveness. This was an observational study conduct...

Descripción completa

Detalles Bibliográficos
Autores principales: Lucas, Joana, Costa, Eduardo, Subtil, Ana, Sequeira, Rita, Campos Fernandes, Adalberto, Robalo Nunes, António, Sousa, Paulo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652329/
https://www.ncbi.nlm.nih.gov/pubmed/36369296
http://dx.doi.org/10.1038/s41598-022-21929-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652329/
https://www.ncbi.nlm.nih.gov/pubmed/36369296
http://dx.doi.org/10.1038/s41598-022-21929-3

Ejemplares similares